Teva Resolves Glaxo IP Suit Over Generic Combivir

Law360, New York (May 27, 2010, 12:34 PM EDT) -- GlaxoSmithKline PLC unit Glaxo Group Ltd. has settled its suit accusing Israel-based generics maker Teva Pharmaceuticals USA Inc. of patent infringement for planning to make its own version of HIV drug Combivir.

Magistrate Judge Leonard P. Stark of the U.S. District Court for the District of Delaware dismissed the case Wednesday, though terms of the deal were not disclosed. Attorneys for the companies could not be reached for comment Thursday.

Teva had planned to launch a generic version earlier in May, and Glaxo had asked the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.